Genomics

Dataset Information

0

CRISPR screen identifies genes that sensitize AML cells to double negative T cell therapy [RNA-Seq]

ABSTRACT: CRISPR screen identifies genes that sensitize AML cells to double negative T cell therapy [RNA-Seq]

PROVIDER: PRJNA662239 | ENA |

REPOSITORIES: ENA

Json Xml

Dataset's files

Source:
Action DRS
SRR12606700_1.fastq.gz Fastqsanger.gz
SRR12606700_2.fastq.gz Fastqsanger.gz
SRR12606701_1.fastq.gz Fastqsanger.gz
SRR12606701_2.fastq.gz Fastqsanger.gz
SRR12606702_1.fastq.gz Fastqsanger.gz
Items per page:
1 - 5 of 16

Similar Datasets

Genomics CRISPR screen identifies genes that sensitize AML cells to double negative T cell therapy
| PRJNA662233 | ENA
Genomics CRISPR screen identifies genes that sensitize AML cells to double negative T cell therapy [guide RNA]
| PRJNA661568 | ENA
Transcriptomics CRISPR screen identifies genes that sensitize AML cells to double negative T cell therapy [RNA-Seq]
2020-12-14 | GSE157617 | GEO
Other CRISPR screen identifies genes that sensitize AML cells to double negative T cell therapy [guide RNA]
2020-12-14 | GSE157527 | GEO
Transcriptomics CRISPR screen identifies genes that sensitize AML cells to double negative T cell therapy
2020-12-14 | GSE157618 | GEO
Genomics Genome wide CRISPR screen in AML chemotherapy resistance.
| PRJNA986910 | ENA
Genomics DNA double strand breaks in KMT2A-rearranged AML patients
| PRJNA805339 | ENA
Genomics DNA double strand breaks in KMT2A-rearranged AML patients
| PRJNA805340 | ENA
Transcriptomics A kinome-wide CRISPR screen identifies CK1α as a novel target to overcome enzalutamide resistance of prostate cancer
2023-03-10 | GSE203362 | GEO
Transcriptomics Transcription profiling of human newly diagnosed AML CEBPA double and single mutant and CEBPA wild type AML.
2009-01-23 | E-GEOD-14468 | biostudies-arrayexpress